Patent ID: 7351717
Filing Date: 2008-04-01
Classification: A61K,A61P,C07D

Abstract:
1. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier and a therapeutically effective amount of a compound having the formula: wherein: each R 1 and R 2 is independently selected from C 1-4 alkyl, C 2-4 alkenyl, C 2-4 alkynyl, C 3-6 cycloalkyl, cyano, halo —OR a , —SR a , —S(O)R a , —S(O) 2 R a and —NR b R c ; or two adjacent R 1 groups or two adjacent R 2 groups are joined to form C 3-6 alkylene, —(C 2-4 alkylene)-O— or —O—(C 1-4 alkylene)-O—; each R each R R each R each R each R each R a is an integer from 0 to 3; b is an integer from 0 to 3; c is an integer from 0 to 4; d is 1 or 2; e is 8 or 9; wherein each alkyl, alkylene, alkenyl, alkynyl and cycloalkyl group in R or a pharmaceutically-acceptable salt or solvate or stereoisomer thereof.